Innovative new technologies like iSWEEP, embodied in iART and iDVT, clearly demonstrate that peripheral thrombectomy does not have to compromise. No longer do practitioners need...
Author: iCHOR
The Memo: iCHOR Vascular Simply Taking a Proven Surgical Fogarty Sweep Into the Endovascular Labs
Under the leadership of Co-Founder and CEO Tim Blair, ICHOR Vascular Inc. is advancing a new approach to treating peripheral vascular occlusions by converting one...
Thrombectomy Opportunities in Peripheral Artery and Vein Sub-markets
Executive Summary for Investors and Strategic Partners The perception that thrombectomy is “crowded” often stems from evaluating the category in aggregate rather than by addressable...
